Minocycline for amyotrophic lateral sclerosis or motor neuron disease
Información
- DOI:
- https://doi.org/10.1002/14651858.CD006840Copiar DOI
- Base de datos:
-
- Cochrane Database of Systematic Reviews
- Versión publicada:
-
- 17 octubre 2007see what's new
- Tipo:
-
- Intervention
- Etapa:
-
- Protocol
- Grupo Editorial Cochrane:
-
Grupo Cochrane de Neuromuscular
- Copyright:
-
- Copyright © 2010 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Cifras del artículo
Altmetric:
Citado por:
Autores
Contributions of authors
R Addison‐Jones and S Sathasivam will identify all the titles and abstracts for the review. These will be checked by CA Young and R Miller. Methods of statistical analysis were suggested by DH Moore. All were involved in writing the protocol and will be involved in writing the review.
Sources of support
Internal sources
-
California Pacific Medical Centre, USA.
-
Royal Preston Hospital, UK.
-
The Walton Centre for Neurology and Neurosurgery, UK.
External sources
-
No sources of support supplied
Declarations of interest
Dr Dan Moore and Dr Robert Miller are involved in a trial of minocycline in ALS or MND sponsored by the National Institutes of Health. Dr Young is involved in a trial of minocycline in ALS or MND sponsored by the Medical Research Council.
Acknowledgements
None
Version history
Published | Title | Stage | Authors | Version |
2021 Nov 18 | Minocycline for amyotrophic lateral sclerosis or motor neuron disease | Protocol | Sivakumar Sathasivam, Robert Addison-Jones, Robert G Miller, Dan H Moore, Carolyn A Young | |
2007 Oct 17 | Minocycline for amyotrophic lateral sclerosis or motor neuron disease | Protocol | Sivakumar Sathasivam, Robert Addison‐Jones, Robert G Miller, Dan H Moore, Carolyn A Young | |